Increased expression of 14-3-3β promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma

American Journal of Pathology

Volumn 179, Issue 6, 2011, Pages 2698-2708

  Liu, Tzu An ^a   Jan, Yee Jee ^b,c   Ko, Bor Sheng ^a,d   Chen, Shyh Chang ^b   Liang, Shu Man ^a   Hung, Ya Lin ^a   Hsu, Chiun ^e   Shen, Tang Long ^d   Lee, Yen Ming ^f,g   Chen, Pei Feng ^a   Wang, John ^b   Shyue, Song Kun ^f   Liou, Jun Yang ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^g NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

14 3 3BETA PROTEIN; PROTEIN 14 3 3; UNCLASSIFIED DRUG;

ADULT; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRAHEPATIC METASTASIS; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; METASTASIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STABLE EXPRESSION;

14-3-3 PROTEINS; ADULT; AGED; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 81255199249     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.08.010     Document Type: Article

References (56)

1. M. Sherman Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis Semin Liver Dis 30 2010 3 16
2. B. Rampone, B. Schiavone, A. Martino, C. Viviano, and G. Confuorto Current management strategy of hepatocellular carcinoma World J Gastroenterol 15 2009 3210 3216
3. M. Natsuizaka, T. Omura, T. Akaike, Y. Kuwata, K. Yamazaki, T. Sato, Y. Karino, J. Toyota, T. Suga, and M. Asaka Clinical features of hepatocellular carcinoma with extrahepatic metastases J Gastroenterol Hepatol 20 2005 1781 1787 (Pubitemid 43961087)
4. K. Hasegawa, and N. Kokudo Surgical treatment of hepatocellular carcinoma Surg Today 39 2009 833 843
5. A. Aitken 14-3-3 proteins: a historic overview Semin Cancer Biol 16 2006 162 172 (Pubitemid 43796128)
6. D.K. Morrison The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development Trends Cell Biol 19 2009 16 23
7. G. Tzivion, V.S. Gupta, L. Kaplun, and V. Balan 14-3-3 proteins as potential oncogenes Semin Cancer Biol 16 2006 203 213 (Pubitemid 43810260)
8. Z. Li, J. Zhao, Y. Du, H.R. Park, S.Y. Sun, L. Bernal-Mizrachi, A. Aitken, F.R. Khuri, and H. Fu Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation Proc Natl Acad Sci U S A 105 2008 162 167
9. C.L. Neal, J. Yao, W. Yang, X. Zhou, N.T. Nguyen, J. Lu, C.G. Danes, H. Guo, K.H. Lan, J. Ensor, W. Hittelman, M.C. Hung, and D. Yu 14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival Cancer Res 69 2009 3425 3432
10. W. Qi, X. Liu, D. Qiao, and J.D. Martinez Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues Int J Cancer 113 2005 359 363 (Pubitemid 40038701)
11. S. Liang, G. Shen, Q. Liu, Y. Xu, L. Zhou, S. Xiao, Z. Xu, F. Gong, C. You, and Y. Wei Isoform-specific expression and characterization of 14-3-3 proteins in human glioma tissues discovered by stable isotope labeling with amino acids in cell culture-based proteomic analysis Proteomics Clin Appl 3 2009 743 753
12. X. Yang, W. Cao, H. Lin, W. Zhang, W. Lin, L. Cao, H. Zhen, J. Huo, and X. Zhang Isoform-specific expression of 14-3-3 proteins in human astrocytoma J Neurol Sci 276 2009 54 59
13. D.Q. Li, L. Wang, F. Fei, Y.F. Hou, J.M. Luo, R. Zeng, J. Wu, J.S. Lu, G.H. Di, Z.L. Ou, Q.C. Xia, Z.Z. Shen, and Z.M. Shao Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry Proteomics 6 2006 3352 3368 (Pubitemid 43886152)
14. B. Yi, S.X. Tan, C.E. Tang, W.G. Huang, A.L. Cheng, C. Li, P.F. Zhang, M.Y. Li, J.L. Li, H. Yi, F. Peng, Z.C. Chen, and Z.Q. Xiao Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma J Cell Biochem 106 2009 858 866
15. D.J. Li, G. Deng, Z.Q. Xiao, H.X. Yao, C. Li, F. Peng, M.Y. Li, P.F. Zhang, Y.H. Chen, and Z.C. Chen Identificating 14-3-3 sigma as a lymph node metastasis-related protein in human lung squamous carcinoma Cancer Lett 279 2009 65 73
16. N. Iwata, H. Yamamoto, S. Sasaki, F. Itoh, H. Suzuki, T. Kikuchi, H. Kaneto, S. Iku, I. Ozeki, Y. Karino, T. Satoh, J. Toyota, M. Satoh, T. Endo, and K. Imai Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma Oncogene 19 2000 5298 5302
17. J. Akahira, Y. Sugihashi, T. Suzuki, K. Ito, H. Niikura, T. Moriya, M. Nitta, H. Okamura, S. Inoue, H. Sasano, K. Okamura, and N. Yaegashi Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation Clin Cancer Res 10 2004 2687 2693 (Pubitemid 38509143)
18. A. Guweidhi, J. Kleeff, N. Giese, J. El Fitori, K. Ketterer, T. Giese, M.W. Buchler, M. Korc, and H. Friess Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis Carcinogenesis 25 2004 1575 1585 (Pubitemid 39214299)
19. H. Nakayama, T. Sano, A. Motegi, T. Oyama, and T. Nakajima Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma Pathol Int 55 2005 707 715 (Pubitemid 41726937)
20. D. Neupane, and M. Korc 14-3-3sigma Modulates pancreatic cancer cell survival and invasiveness Clin Cancer Res 14 2008 7614 7623
21. K. Tanaka, T. Hatada, M. Kobayashi, Y. Mohri, H. Tonouchi, C. Miki, T. Nobori, and M. Kusunoki The clinical implication of 14-3-3 sigma expression in primary gastrointestinal malignancy Int J Oncol 25 2004 1591 1597
22. Y. Kuramitsu, B. Baron, S. Yoshino, X. Zhang, T. Tanaka, M. Yashiro, K. Hirakawa, M. Oka, and K. Nakamura Proteomic differential display analysis shows up-regulation of 14-3-3 sigma protein in human scirrhous-type gastric carcinoma cells Anticancer Res 30 2010 4459 4465
23. E. Hayashi, Y. Kuramitsu, M. Fujimoto, X. Zhang, T. Tanaka, K. Uchida, T. Fukuda, H. Furumoto, Y. Ueyama, and K. Nakamura Proteomic profiling of differential display analysis for human oral squamous cell carcinoma: 14-3-3 sigma protein is upregulated in human oral squamous cell carcinoma and dependent on the differentiation level Proteomics Clin Appl 3 2009 1338 1347
24. H. Okumura, Y. Kita, N. Yokomakura, Y. Uchikado, T. Setoyama, H. Sakurai, I. Omoto, M. Matsumoto, T. Owaki, S. Ishigami, and S. Natsugoe Nuclear expression of 14-3-3 sigma is related to prognosis in patients with esophageal squamous cell carcinoma Anticancer Res 30 2010 5175 5179
25. Y. Takihara, Y. Matsuda, and J. Hara Role of the beta isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation Carcinogenesis 21 2000 2073 2077
26. A. Sugiyama, Y. Miyagi, Y. Komiya, N. Kurabe, C. Kitanaka, N. Kato, Y. Nagashima, Y. Kuchino, and F. Tashiro Forced expression of antisense 14-3-3beta RNA suppresses tumor cell growth in vitro and in vivo Carcinogenesis 24 2003 1549 1559 (Pubitemid 37160846)
27. T.J. Musholt, C. Brehm, J. Hanack, R. von Wasielewski, and P.B. Musholt Identification of differentially expressed genes in papillary thyroid carcinomas with and without rearrangements of the tyrosine kinase receptors RET and/or NTRK1 J Surg Res 131 2006 15 25 (Pubitemid 43227579)
28. Y. Zeng, Y. Li, R.S. Chen, X. He, L. Yang, and W. Li Overexpression of xCT induces up-regulation of 14-3-3beta in Kaposi's sarcoma Biosci Rep 30 2010 277 283
29. J.M. Llovet, C. Bru, and J. Bruix Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 1999 329 338
30. D.M. Barnes, W.H. Harris, P. Smith, R.R. Millis, and R.D. Rubens Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients Br J Cancer 74 1996 1445 1451 (Pubitemid 26370738)
31. G.C. Chang, K.J. Liu, C.L. Hsieh, T.S. Hu, S. Charoenfuprasert, H.K. Liu, K.T. Luh, L.H. Hsu, C.W. Wu, C.C. Ting, C.Y. Chen, K.C. Chen, T.Y. Yang, T.Y. Chou, W.H. Wang, J. Whang-Peng, and N.Y. Shih Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes Clin Cancer Res 12 2006 5746 5754 (Pubitemid 44629605)
32. Y.J. Jan, B.S. Ko, C. Hsu, T.C. Chang, S.C. Chen, J. Wang, and J.Y. Liou Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma Hum Pathol 40 2009 1384 1390
33. B.S. Ko, T.C. Chang, C. Hsu, Y.C. Chen, T.L. Shen, S.C. Chen, J. Wang, K.K. Wu, Y.J. Jan, and J.Y. Liou Overexpression of 14-3-3epsilon predicts tumor metastasis and poor survival in hepatocellular carcinoma Histopathology 58 2011 705 711
34. B.S. Ko, I.R. Lai, T.C. Chang, T.A. Liu, S.C. Chen, J. Wang, Y.J. Jan, and J.Y. Liou Involvement of 14-3-3gamma overexpression in extrahepatic metastasis of hepatocellular carcinoma Hum Pathol 42 2011 129 135
35. F.G. Buchanan, D.L. Gorden, P. Matta, Q. Shi, L.M. Matrisian, and R.N. DuBois Role of beta-arrestin 1 in the metastatic progression of colorectal cancer Proc Natl Acad Sci U S A 103 2006 1492 1497 (Pubitemid 43191193)
36. H.B. Guo, I. Lee, M. Kamar, S.K. Akiyama, and M. Pierce Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration Cancer Res 62 2002 6837 6845 (Pubitemid 35424070)
37. F. Hohla, A.V. Schally, C.A. Kanashiro, S. Buchholz, B. Baker, C. Kannadka, A. Moder, E. Aigner, C. Datz, and G. Halmos Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt Proc Natl Acad Sci U S A 104 2007 18671 18676 (Pubitemid 350210755)
38. M. Kidd, I.M. Modlin, R. Pfragner, G.N. Eick, M.C. Champaneria, A.K. Chan, R.L. Camp, and S.M. Mane Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1 Cancer 109 2007 2420 2431 (Pubitemid 46906460)
39. S. Nowacki, M. Skowron, A. Oberthuer, A. Fagin, H. Voth, B. Brors, F. Westermann, A. Eggert, B. Hero, F. Berthold, and M. Fischer Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma Oncogene 27 2008 3329 3338 (Pubitemid 351733395)
40. M. Santra, X. Zhang, S. Santra, F. Jiang, and M. Chopp Ectopic doublecortin gene expression suppresses the malignant phenotype in glioblastoma cells Cancer Res 66 2006 11726 11735 (Pubitemid 46098830)
41. C.M. Chang, C.H. Lo, Y.M. Shih, Y. Chen, P.Y. Wu, K. Tsuneyama, S.R. Roffler, and M.H. Tao Treatment of hepatocellular carcinoma with adeno-associated virus encoding interleukin-15 superagonist Hum Gene Ther 21 2010 611 621
42. D.L. Ou, Y.C. Shen, J.D. Liang, J.Y. Liou, S.L. Yu, H.H. Fan, D.S. Wang, Y.S. Lu, C. Hsu, and A.L. Cheng Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma Clin Cancer Res 15 2009 5820 5828
43. W.J. Fantl, A.J. Muslin, A. Kikuchi, J.A. Martin, A.M. MacNicol, R.W. Gross, and L.T. Williams Activation of Raf-1 by 14-3-3 proteins Nature 371 1994 612 614 (Pubitemid 24315743)
44. S. Li, P. Janosch, M. Tanji, G.C. Rosenfeld, J.C. Waymire, H. Mischak, W. Kolch, and J.M. Sedivy Regulation of Raf-1 kinase activity by the 14-3-3 family of proteins EMBO J 14 1995 685 696
45. Y. Komiya, N. Kurabe, K. Katagiri, M. Ogawa, A. Sugiyama, Y. Kawasaki, and F. Tashiro A novel binding factor of 14-3-3beta functions as a transcriptional repressor and promotes anchorage-independent growth, tumorigenicity, and metastasis J Biol Chem 283 2008 18753 18764
46. Y. Li, K. Inoki, R. Yeung, and K.L. Guan Regulation of TSC2 by 14-3-3 binding J Biol Chem 277 2002 44593 44596 (Pubitemid 36159047)
47. S.D. Shumway, Y. Li, and Y. Xiong 14-3-3beta binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin J Biol Chem 278 2003 2089 2092 (Pubitemid 36801271)
48. D.C. Han, L.G. Rodriguez, and J.L. Guan Identification of a novel interaction between integrin beta1 and 14-3-3beta Oncogene 20 2001 346 357 (Pubitemid 32142324)
49. L.G. Rodriguez, and J.L. Guan 14-3-3 regulation of cell spreading and migration requires a functional amphipathic groove J Cell Physiol 202 2005 285 294
50. P.R. Somanath, and T.V. Byzova 14-3-3beta-Rac1-p21 activated kinase signaling regulates Akt1-mediated cytoskeletal organization, lamellipodia formation and fibronectin matrix assembly J Cell Physiol 218 2009 394 404
51. J.Y. Liou, S. Lee, D. Ghelani, N. Matijevic-Aleksic, and K.K. Wu Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation Arterioscler Thromb Vasc Biol 26 2006 1481 1487 (Pubitemid 44288972)
52. J.Y. Liou, C.C. Wu, B.R. Chen, L.B. Yen, and K.K. Wu Nonsteroidal anti-inflammatory drugs induced endothelial apoptosis by perturbing peroxisome proliferator-activated receptor-delta transcriptional pathway Mol Pharmacol 74 2008 1399 1406
53. G.W. Porter, F.R. Khuri, and H. Fu Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways Semin Cancer Biol 16 2006 193 202 (Pubitemid 43796125)
54. J.Y. Liou, D. Ghelani, S. Yeh, and K.K. Wu Non-steroidal anti-inflammation drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3ε Cancer Res 67 2007 3185 3191 (Pubitemid 46724856)
55. Y. Hong, S.W. Jang, and K. Ye The N-terminal fragment from caspase-cleaved serine/arginine protein-specific kinase2 (SRPK2) translocates into the nucleus and promotes apoptosis J Biol Chem 286 2011 777 786
56. H.K. Lin, G. Wang, Z. Chen, J. Teruya-Feldstein, Y. Liu, C.H. Chan, W.L. Yang, H. Erdjument-Bromage, K.I. Nakayama, S. Nimer, P. Tempst, and P.P. Pandolfi Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB Nat Cell Biol 11 2009 420 432